Literature DB >> 27088385

FLT PET/CT in a Case of Demyelinating Disease.

Alexandra Nikaki1, Vasilios Prassopoulos, Roxani Efthimiadou, Ioannis Tsougos, Panagiotis Georgoulias.   

Abstract

A 32-year-old woman, with spare previous medical history, presented with neurological symptoms of numbness and diplopia. The patient underwent brain MRI, which revealed a lesion of abnormal signal in the midbrain that could be attributed to subacute stroke; however, consecutive MRIs revealed multiple lesions of abnormal signal pointing to demyelinating disease. During symptoms investigation and MRI findings assessment, the patient underwent a FLT PET/CT examination, which revealed lesions of increased FLT uptake, probably indicating active disease and blood-brain barrier disruption.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27088385     DOI: 10.1097/RLU.0000000000001229

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  2 in total

1.  In vivo imaging of cell proliferation in meningioma using 3'-deoxy-3'-[18F]fluorothymidine PET/MRI.

Authors:  Asma Bashir; Tina Binderup; Mark Bitsch Vestergaard; Helle Broholm; Lisbeth Marner; Morten Ziebell; Kåre Fugleholm; Andreas Kjær; Ian Law
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-02-11       Impact factor: 9.236

2.  Progressive Tumefactive Demyelination as the Only Result of Extensive Diagnostic Work-Up: A Case Report.

Authors:  Pavel Štourač; Jan Kolčava; Miloš Keřkovský; Tereza Kopřivová; Leoš Křen; Josef Bednařík
Journal:  Front Neurol       Date:  2021-07-08       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.